Results 131 to 140 of about 55,054 (301)
ABSTRACT Alzheimer's disease (AD) is one of the most common neurodegenerative disorders characterized by the accumulation of amyloid‐β (Aβ) peptide and phosphorylated tau protein in the brain. Despite intensive efforts, early diagnosis and monitoring of AD remain challenging due to the lack of reliable biomarkers that can detect the disease in its ...
Ceren Perihan Gonul+2 more
wiley +1 more source
We have reviewed the binding of antimuscarinic agents, used to treat urinary dysfunction in patients with overactive bladder, to muscarinic receptors in target and non-target tissues in vivo.
Akira Yoshida+5 more
doaj
Astrocytes Reduce Store-Operated Ca2+ Entry in Microglia under the Conditions of an Inflammatory Stimulus and Muscarinic Receptor Blockade. [PDF]
Kim YJ, Shin YK, Seo E, Seol GH.
europepmc +1 more source
Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea‐pig [PDF]
David Faulkner+2 more
openalex +1 more source
ABSTRACT Obstructive sleep apnea (OSA), characterized by repetitive upper airway obstruction, leads to chronic intermittent hypoxia (cIH) and induces cognitive and neuronal network disruptions similar to those observed in Alzheimer's disease (AD). These pathologies are often presented together in the elderly and share some pathophysiological mechanisms.
Pinedo‐Vargas Laura+4 more
wiley +1 more source
The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β2 Adrenergic Receptor Agonist Navafenterol in Human Small Airways. [PDF]
Jude JA+4 more
europepmc +1 more source
The effect of McN‐A‐343 on muscarinic receptors in the cerebral cortex and heart [PDF]
N.J.M. Birdsall+4 more
openalex +1 more source
The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer
Organs interact dynamically through immune regulation, influencing systemic immune responses and disease progression. We review molecular and cellular mechanisms of cross‐organ immune regulation in inflammation and cancer, focusing on gut, liver, and brain interactions with other organs.
Jie Dou+6 more
wiley +1 more source
Previously we reported the cholinergic M2 muscarinic receptor-mediated inhibition of noradrenaline release from the rat stomach (K. Yokotani, Y. Osumi. J Pharmacol Exp Ther. 1993;264:54–60).
Kumiko Nakamura+5 more
doaj